Hypoxia and Cancer: Biological Implications and Therapeutic Opportunities (Cancer Drug Discovery and Development)
Price Rs.81,080.00
Product Code:
1493953559
Weight:
1.28 Pounds
Availability: Instock in US ✔
Import from USA in Pakistan
Important: Delivery of this product will take 3 to 4 weeks.
⚠️️ Shoppingbag.pk's Advice
- Before ordering any product, please make sure the product technically fulfills your need and contains no illegal ingredients (e.g., wine, alcohol, pig, pork, animal-based gelatin, etc.) or contents.
- For technical support or manufacturer's warranty of the products found on shoppingbag.pk, you can contact directly with the original manufacturer or visit their website.
- We are your importer of goods from the USA, UK, China, Russia, etc., and will not provide any technical support, product warranty, or quality check.
- Our enlarged and enhanced product pictures may differ slightly from the original products. Also, read product reviews and ratings before buying.
- Since dollar rate keeps fluctuating, prices are not confirmed on our website.
- We take 30% advance of the total value and the remaining payment is done at the time of delivery.
- We are assuming you have read our terms and conditions and agreed with them.
Product Detail
​​​The imbalance between rapidly proliferating tumor cells and inadequate and inefficient tumor vasculature leads to a decrease in oxygen levels (hypoxia and/or anoxia) in tumor tissues. Intra-tumor hypoxia profoundly affects the biological behavior of cancer cells, which become resistant to conventional therapies and acquire a more invasive and metastatic phenotype. Hypoxia is a hallmark of the malignant phenotype and a key feature of the tumor microenvironment. Hypoxia Inducible Factor 1 (HIF-1) is a master regulator of the transcriptional response to oxygen deprivation. HIF triggers the expression of genes whose products induce angiogenesis, decrease oxygen consumption, switch metabolism to glycolysis, maintain a stem cell phenotype and select for more invasive and metastatic cells. Therapeutic approaches targeting HIF, directly or downstream mediators of its transcriptional activity, are being developed. Intra-tumor hypoxia is a topic has been gaining scientific interest over the last few years for its wide involvement in many physiological and pathological processes.ÂThis volume will cover the latest research and translational aspects associated with intra-tumor hypoxia, along with opportunities for drug development offered by this unique feature of the tumor microenvironment. The ongoing efforts to translate our understanding of the biology underlying intra-tumor hypoxia in viable therapeutic options face many challenges, but this book will provide an opportunity for an in-depth analysis of the fundamental mechanisms implicated in the adaption to low oxygen levels and will scrutinize the potential for opportunities that are being pursued in both research and the drug development industry. Binding: PaperbackEAN: 9781493953554Edition: Softcover reprint of the original 1st ed. 2014ISBN: 1493953559Label: Humana PressManufacturer: Humana PressNumberOfItems: 1NumberOfPages: 363ProductGroup: BookProductTypeName: ABIS_BOOKPublicationDate: 2016-08-23Publisher: Humana PressReleaseDate: 2016-08-23Studio: Humana PressTitle: Hypoxia and Cancer: Biological Implications and Therapeutic Opportunities (Cancer Drug Discovery and Development)
